Australia HIV Drugs Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4161

  • Format: PPT, PDF

Australia HIV Drugs Market: Segmented by Medication Class (Nucleoside Reverse Transcriptase Inhibitors, Multi-Class Combination Drugs, Protease Inhibitors, Fusion Inhibitors, Entry Inhibitors, HIV Integrase Strand Transfer Inhibitors, & Non-Nucleoside Reverse Transcriptase Inhibitors), & by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies)- Growth, Trends, And Forecasts (2019 – 2028)


Report Overview

The Australian HIV drug market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In 2019, approximately 0.1% of the total population of Australia had HIV 2019. HIV is a virus that can damage the immune system and make it difficult for the body to fight off simple infections. HIV is not the same as AIDS. If left untreated, HIV can lead to AIDS. However, with highly effective HIV treatments now available, AIDS is extremely rare in Australia. HIV is spread through body fluids including blood, semen, vaginal fluids, anal mucus, and breastmilk, and from mother to child. HIV cannot be spread through – saliva or kissing, hugging, or shaking hands, toilet seats, insect bites, sharing cutlery or crockery, or by eating food prepared by someone who is HIV-positive. The increasing awareness regarding the severity of HIV AIDS has created a huge emphasis on several drugs, related to the treatment of this disease. The side effects of HIV/AIDS have led to several drug innovations, particularly aimed at the efficient treatment of patients with advanced stages of the disease. The report encompasses several factors that have contributed to the growth of the market in recent years.

Market Drivers

The market is majorly driven by increasing drug approvals, High prevalence of HIV/AIDS. The increasing emphasis on the research and development of HIV/AIDS drugs has led to several drug innovations in recent years. The increasing demand for therapeutic procedures and treatment methods has created a subsequent emphasis on the development of related drugs. The rising prevalence of HIV/AIDS has resulted in an increased emphasis on the development of treatment methods and drugs associated with the treatment of this disease. Due to the increasing incidence of HIV/AIDS, HIV/AIDS drug companies have witnessed massive growth opportunities in recent years.

Epidemiology of HIV

In 2019, it was estimated that there were 29,045 people with HIV in Australia. Of these 29,045 people, an estimated 90% were diagnosed by the end of 2019. The research also shows that 91% of people diagnosed were receiving HIV treatment, and of those on treatment, 97% had an undetectable viral load.

The number of HIV notifications newly diagnosed in Australia has remained stable from 2012-2016, with 1013 new diagnoses in 2016. 26,444(0.1% of the total population of Australia) people with HIV in 2016. An estimated 7.3% prevalence among gay and bisexual men and an estimated 1.4% prevalence among people who inject drugs.

Of the estimated 26,444 people living with HIV in 2016, 89% were diagnosed by the end of 2016 and of those diagnosed 95% were retained in care, 86% were receiving ART, and of those on ART, 93% had achieved viral suppression.

1. Australia HIV Drugs Market Overview………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in Prevalence of HIV
B. Initiatives by various government associations
C. Introduction of generic drugs of HIV drugs
3. Epidemiology of HIV………………………………………………….
A. Prevalence of HIV cases
B. Incidence of HIV cases
C. Diagnosed and treated cases of HIV
4. HIV Drugs Market Segmentation………………………………………
A. Medication Class
I. Nucleoside Reverse Transcriptase Inhibitors
II. Multi-Class Combination Drugs
III. Protease Inhibitors
IV. Fusion Inhibitors
V. Entry Inhibitors
VI. HIV Integrase Strand Transfer Inhibitors
VII. Non-Nucleoside Reverse Transcriptase Inhibitors
B. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. HIV Drugs Major Drugs Market Share………………………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Boehringer Ingelheim Company overview, Product & Services, Strategies & Financials
B. Gilead Sciences Company overview, Product & Services, Strategies & Financials
C. F. Hoffmann-La Roche Ltd Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………….
A. New Trends and Development of HIV Drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Medication Class:

Based on medication class, the market is classified into multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FI), entry inhibitors, and HIV integrase strand transfer inhibitors. The multi-class combination drugs segment holds the largest market share as it involves the most advanced technology used for the treatment of HIV infection. Furthermore, this is attributed to the increase in adoption of drugs from this medication class owing to their better results in the control of HIV & related co-infections and their ease in consumption & adherence.

By Distribution Channel:

Based on the distribution channel, the market for cardiovascular drugs can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital segment is expected to dominate the market throughout the forecast period. The increasing number of clinics is propelling the growth of the specialty clinics segment.

Major Players

Key players that operate in the HIV drugs market, such as Boehringer Ingelheim International GmbH, Merck & Co., Inc., Pfizer Inc., Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., AbbVie, Bristol- Myers Squibb, and Cipla.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements